Regulation of Gammaherpesviral Late Gene Expression
- Institution
- UNIVERSITY OF CALIFORNIA BERKELEY, CA
- Principal investigator
- Britt A Glaunsinger
- Funding
- $386K
- Duration
- 2015–2026
Moonbase score
Still being scored
Abstract
ABSTRACT Herpesviruses are endemic within the human population, and cause a wide range of life-threatening diseases. Members of the betaherpesvirus and gammaherpesvirus subfamilies are extremely problematic in immunocompromised individuals, leading to severe congenital disorders and a variety of cancers. This proposal will define how a critical class of herpesviral genes are expressed late in the lifecycle of Kaposi's sarcoma-associated herpesvirus (KSHV) through a mechanism that involves a novel transcription complex, which combines both viral mimicry and co-option of select host machinery. The set of viral proteins required for late gene activation are broadly conserved among the beta- and gammaherpesviruses, indicating that information gained herein for KSHV will likely be applicable for Epstein-Barr virus and human cytomegalovirus as well. The focus of this grant is to define the composition and regulation of this novel gene expression complex, and reveal how its function is linked to viral genome replication. Given that even subtle mutations in this late gene transcription complex effectively `kill' the virus, an understanding of its composition and regulation is anticipated to reveal new targets for antiviral strategies.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF CALIFORNIA BERKELEY
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of California BerkeleyNot yet scored
Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus
Britt A Glaunsinger · $392K · 2010–2030
- NIH · University of California Berkeley48
Leveraging Single Cell Stimulation to Untangle Parallel Perceptual Pathways in the Human Retina
Leah Johnston · $47K · 2024–2027
- NIH · University of California Berkeley48
Discovery and Development of Organic Reactions Catalyzed by Transition Metals Valuable for Medicinal Chemistry
John F Hartwig · $832K · 2019–2027